Skip to main content
SpringerLink
Log in

Successful treatment of adalimumab-induced paradoxical reaction with risankizumab in a patient with psoriatic arthritis

  • Correspondence
  • Published:
European Journal of Dermatology

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Collamer AN, Battafarano DF. Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: clinical features and possible immunopathogenesis. Semin Arthritis Rheum 2010; 40: 23340.

    Article  Google Scholar 

  2. Tillack C, Ehmann LM, Friedrich M, et al. Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon—γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment. Gut 2014; 63: 567–77.

    Article  CAS  Google Scholar 

  3. Pugliese D, Guidi L, Ferraro PM, et al. Paradoxical psoriasis in a large cohort of patients with inflammatory bowel disease receiving treatment with anti-TNF alpha: 5-year follow-up study. Aliment Pharmacol Ther 2015; 42: 880–8.

    Article  CAS  Google Scholar 

  4. Bogaards NA, de Rie MA. Psoriasiform eruption and worsening of pustulosis palmoplantaris after treatment with two anti-TNF-α inhibitors, followed by successful treatment with ustekinumab. Dermatol Ther (Heidelb) 2016; 6: 683–8.

    Article  Google Scholar 

  5. Visvanathan S, Baum P, Vinisko R, et al. Psoriatic skin molecular and histopathologic profiles after treatment with risankizumab versus ustekinumab. J Allergy Clin Immunol 2019; 143: 2158–69.

    Article  CAS  Google Scholar 

  6. Georgescu SR, Tampa M, Caruntu C, et al. Advances in understanding the immunological pathways in psoriasis. Int J Mol Sci 2019; 20: 739.

    Article  CAS  Google Scholar 

  7. Kannan AK, Su Z, Gauvin DM, et al. IL-23 induces regulatory T cell plasticity with implications for inflammatory skin diseases. Sci Rep 2019; 9: 17675.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, Iwate Medical University School of Medicine, 2-1-1, Idaidori, Yahabacho, Iwate, 028-3695, Japan

    Daisuke Watabe & Hiroo Amano

Authors
  1. Daisuke Watabe
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hiroo Amano
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Daisuke Watabe.

Additional information

Disclosure

Conflicts of interest: none.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Watabe, D., Amano, H. Successful treatment of adalimumab-induced paradoxical reaction with risankizumab in a patient with psoriatic arthritis. Eur J Dermatol 30, 611–612 (2020). https://doi.org/10.1684/ejd.2020.3859

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1684/ejd.2020.3859

Search

Navigation